ARTICLE | Clinical News
Belviq lorcaserin regulatory update
February 23, 2015 8:00 AM UTC
Arena said South Korea approved Belviq lorcaserin as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with a BMI >=30 kg/m 2 or >=27 kg/m 2 ...